Anika therapeutics says q2 revenue rose 1 percent to $30.7 million

Anika reports second quarter 2020 financial results.q2 loss per share $0.54.q2 revenue rose 1 percent to $30.7 million.q2 adjusted earnings per share $0.09.launching seven fda-cleared orthopedic and sports medicine products through q3 2020.

ANIK Ratings Summary

ANIK Quant Ranking